New to peptides? Start with the foundations ->
The plain-English version
Standard protocol is 1.6 milligrams (a small subQ shot) twice a week, for 6 to 12 weeks. The branded version (Zadaxin) is approved abroad for hepatitis and chemo support. In the US, it is compounded off-label for general immune support. Always with a doctor.
Route: subcutaneous injection. Evidence tier for the dose: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.
The dose at a glance
| What's typical | What's the max in research |
|---|---|
| Starting dose: 1.6 mg subQ (under-the-skin shot) twice weekly. Some clinicians start at 0.8 mg for sensitive patients. | Max observed in research: Some hepatitis trials used 1.6 mg twice daily for short periods. The standard 1.6 mg twice weekly is the practical maintenance ceiling - more frequent dosing has not shown added benefit. |
| Maintenance dose: 1.6 mg twice weekly during a 6-12 week cycle. | |
| Frequency: Twice weekly. Most protocols use a fixed schedule (Monday and Thursday) to make it routine. | Half-life: About 2 hours in plasma. Tissue effects on T-cell function are believed to last 3-5 days, which is why twice-weekly works. |
Titration (how to ramp the dose)
Most users skip formal titration (slow ramp-up). Some start at 0.8 mg for the first 2 doses to test tolerance.
Cycle length and time off
On cycle: 6 to 12 weeks per cycle. Hepatitis protocols can run longer (up to 6 months) under specialist care.
Off cycle: 4 to 8 weeks off between cycles for general immune support. Continuous dosing is reserved for active hepatitis or chemo support.
Timing notes: Time of day does not matter much. Most users inject morning. Inject in stomach or thigh fat. Rotate sites.
What's commonly prescribed (per published protocols and clinical write-ups)
Branded Zadaxin (manufactured by SciClone Pharmaceuticals) is approved in 35+ countries for hepatitis and chemo support but NOT in the US. US compounding pharmacies dispense Thymosin Alpha-1 as a lyophilized (freeze-dried, shelf-stable) vial, typically 5 mg or 10 mg. Telehealth scripts usually read 'Thymosin Alpha-1 1.6 mg subQ twice weekly x 12 weeks.' Functional and integrative medicine practitioners are the most common prescribers in the US.
Source: prescribing labels, published protocols, and clinical write-ups. We have not independently tested each prescriber pattern.
Reconstitution (mixing the vial)
Lyophilized 5 mg vials reconstitute (mix back into liquid) with exactly 2 mL of bacteriostatic water (sterile water with preservative, the kind compounding pharmacies sell for reconstituting peptides). At 5 mg per 2 mL, every 0.1 mL on the syringe equals 250 mcg, so a 1.6 mg dose is 0.64 mL. If your pharmacy filled the vial with a different volume, recalculate from the mg/mL printed on your vial label - not from this page. Store reconstituted vial in the fridge, use within 30 days.
Reconstitution = mixing freeze-dried (lyophilized) powder with bacteriostatic water (sterile water with preservative) so you can draw a dose into a syringe.
Where to get it
Honest take on where to source this peptide. What fits which user, and what to watch for.
Compounded peptide vendor
Limitless Biotech
Fits: You want a Thymosin Alpha-1 cycle for immune support under prescriber direction, you want a US-based source with published COAs.
Watch: Thymosin Alpha-1 (Zadaxin) is approved in some countries but not the US. Compounded paths exist; insurance coverage does not. Pending affiliate.
(pending) Visit Limitless Biotech ->Compounded peptide vendor
Apollo Peptide Sciences
Fits: You want a second source to cross-check COA, batch availability, or pricing for a longer Thymosin Alpha-1 cycle.
Watch: Same caveats. Pending affiliate.
(pending) Visit Apollo Peptide Sciences ->We're evaluating vendor partnerships across this category. When we have an active affiliate relationship, we disclose it here clearly. As of now: placeholder or pending status per vendor above. Affiliate links don't change our editorial take. We only recommend what we'd actually use.
Drug interactions to watch
- Immunosuppressive drugs (cyclosporine, tacrolimus, prednisone at high doses) - opposing mechanism; coordinate with prescriber.
- Vaccines - may enhance vaccine response; useful timing tool but discuss with your doctor.
- Other immunomodulators - report all current medications to the prescribing clinician.
Who should not take this (contraindications)
- Active organ transplant on immunosuppressants (the drug works against the transplant strategy).
- Active flares of immune-mediated disease (lupus, RA) without rheumatologist sign-off.
- Pregnancy and breastfeeding (no safety data).
- Known hypersensitivity to the peptide.
Common side effects
- Mild fatigue or flu-like feeling in the first 1-2 doses.
- Injection-site reaction (mild redness, soreness).
- Transient low-grade fever (rare, usually first dose only).
Serious side effects (call a doctor)
- Worsening of autoimmune disease - stop and call your rheumatologist.
- Allergic reaction (hives, swelling) - rare but documented.
- Persistent fever or unusual immune-related symptoms.
What to monitor while you're on it
- CBC with differential at baseline and 6 weeks (track lymphocyte counts).
- If using for hepatitis or chronic infection: viral load and liver enzymes per specialist protocol.
- Symptom log - infection frequency, energy, sleep.
How to stop
Just stop at the end of the cycle. No taper needed. T-cell effects fade over weeks.
Where this dosing comes from
- Camerini and Garaci, Thymosin Alpha-1 mechanism review (2010)
- Multiple hepatitis B and C RCTs (Zadaxin clinical program, 1990s-2010s)
- SciClone Pharmaceuticals prescribing information for Zadaxin (international)
- US compounding pharmacy formularies (Tailor Made, Empower, Strive)
Where these doses come from
These doses come from human trials and prescribing protocols used by clinicians. Not FDA-approved at this exact dose, but well-supported by published data.
Always work with a real prescriber. Don't self-prescribe.
Safety reminder: None of this replaces a doctor. Peptides are gray-market in the US for most uses. Talk to a real prescriber before you change anything.
Where to go next
- Full Thymosin Alpha-1 directory entry - status, sourcing, studies, what to skip
- Thymosin Alpha-1 for immune support
- Thymosin Alpha-1 for chronic fatigue
- Thymosin Alpha-1 for autoimmune modulation
- Thymosin Alpha-1 for cancer support
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- Subscribe to the dispatch
Subscribe to the dispatch
The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.
Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine. None of this replaces a doctor. Peptides are gray-market in the US for most uses. Talk to a real prescriber before you change anything.